杜俣,荆全民,刘健,刘巍,钱杰,沈玲红,汪奇,翟光耀,赵林

• 1:准分子激光冠状动脉介入应用中国专家共识工作组
• 2:首都医科大学附属北京安贞医院
• 3:中国人民解放军北部战区总医院
• 4:北京大学人民医院

摘要(Abstract)：

准分子激光冠状动脉消蚀术（ELCA）是一项已在临床应用近30年的医学技术，具有大量的临床研究证据并已获得多个国际心血管专家共识的推荐。但在临床实践中，如何在不同的应用场景中充分发挥该技术的作用依然是一个难题，当前主要依赖术者个人经验。尽管2022年欧洲心血管激光学会发表了冠状动脉介入治疗中准分子激光技术专家立场文件，对ELCA在3种常见应用场景的使用参数进行了简要推荐，但仍需要更详尽的指南指导临床实践。基于既往指南和共识推荐，结合近年来国内外学者对ELCA导管使用经验的积累和研究证据的不断丰富，本专家共识依据ELCA的不同临床适应证对ELCA导管的选择和使用技巧作出具体推荐，以期在临床工作中充分发挥ELCA的作用并减少潜在并发症风险。

关键词(KeyWords)： 准分子激光冠状动脉消蚀术;光消蚀;声压波;空泡效应;血管内超声;光学相干断层成像

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杜俣,荆全民,刘健,刘巍,钱杰,沈玲红,汪奇,翟光耀,赵林

参考文献(References)：

• [1] Basting D,Marowsky G,Excimer Laser Technology[M].Berlin:Springer,2005:27.
• [2] Grundfest WS,Litvack F,Forrester JS,et al. Laser ablation of human atherosclerotic plaque without adjacent tissue injury[J]. J Am Coll Cardiol,1985,5(4):929-933. DOI:10.1016/s0735-1097(85)80435-6.
• [3] Litvack F,Grundfest W,Eigler N,et al. Percutaneous excimer laser coronary angioplasty[J]. Lancet,1989,2(8654):102-103. DOI:10.1016/s0140-6736(89)90339-5.
• [4] Bittl JA,Brinker JA,Sanborn TA,et al. The changing profi le of patient selection,procedural techniques,and outcomes in excimer laser coronary angioplasty. Participating investigators of the percutaneous excimer laser coronary angioplasty registry[J].J Interv Cardiol,1995,8(6):653-660. DOI:10.1111/j.1540-8183.1995.tb00915.x.
• [5]徐成斌，蒋宝琦，王伟民，等.经皮准分子激光冠状动脉成形术的临床研究——附6例报道[J].中国激光医学杂志，1993,2(1):8-11. DOI:10.13480/j.issn1003-9430.1993. 01. 003.
• [6]杜俣，刘巍，周玉杰，等.新型准分子激光冠状动脉斑块消融术在冠状动脉钙化及慢性阻塞性病变中的初步应用[J].中华心血管病杂志（网络版），2019,2(1):1-10. DOI:10.3760/cma.j.issn.20961588.2019.1000018.
• [7] Oraevsky AA,Jacques SL,Pettit GH,et al. XeCl laser ablation of atherosclerotic aorta:optical properties and energy pathways[J]. Lasers Surg Med,1992,12(6):585-597.DOI:10.1002/lsm.1900120604.
• [8] Esenaliev RO,Oraevsky AA,Letokhov VS,et al. Studies of acoustical and shock waves in the pulsed laser ablation of biotissue[J]. Lasers Surg Med,1993,13(4):470-484.DOI:10.1002/lsm.1900130412.
• [9] Appelman YE,Piek JJ,Verhoofstad GG,et al. Tissue ablation and gas formation of two excimer laser systems:an in vitro evaluation on porcine aorta[J]. Lasers Surg Med,1996,18(2):197-205. DOI:10.1002/（SICI）1096-9101(1996)18:2<197::AID-LSM11>3.0.CO;2-5.
• [10] Baumbach A,Haase KK,Rose C,et al. Formation of pressure waves during in vitro excimer laser irradiation in whole blood and the eff ect of dilution with contrast media and saline[J]. Lasers Surg Med,1994,14(1):3-6. DOI:10.1002/lsm.1900140104.
• [11] Basting D,Pippert K,Stamm U. History and future prospects of excimer lasers[C]. International Symposium on Laser Precision Microfabrication,2002.
• [12] Safi an RD,Freed M. The manual of interventional cardiology[J]. 2001.
• [13] Deckelbaum LI,Natarajan MK,Bittl JA,et al. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty:a randomized trial. The Percutaneous Excimer Laser Coronary Angioplasty(PELCA)Investigators[J]. J Am Coll Cardiol,1995,26(5):1264-1269. DOI:10.1016/0735-1097(95)00330-4.
• [14] Appelman YE,Piek JJ,Strikwerda S,et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease[J]. Lancet,1996,347(8994):79-84. DOI:10.1016/s0140-6736(96)90209-3.
• [15] Karacsonyi J,Armstrong EJ,Truong HTD,et al. Contemporary use of laser during percutaneous coronary interventions:insights from the Laser Veterans Aff airs(LAVA)Multicenter Registry[J]. J Invasive Cardiol,2018,30(6):195-201.
• [16] Ambrosini V,Sorropago G,Laurenzano E, et al. Early outcome of high energy Laser(Excimer)facilitated coronary angioplasty on hard and complex calcified and balloon-resistant coronary lesions:LEONARDO Study[J]. Cardiovasc Revasc Med,2015,16(3):141-146. DOI:10.1016/j.carrev.2015.02.002.
• [17] Appelman YE,Koolen JJ,Piek JJ, et al. Excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions[J]. Am J Cardiol,1996,78(7):757-762. DOI:10.1016/s0002-9149(96)00416-x.
• [18] Cobarro L,Jurado-Román A,Tébar-Márquez D,et al. Excimer laser coronary atherectomy in severely calcifi ed lesions:time to bust the myth[J]. REC Interv Cardiol,2023,6(1):33-40.DOI:10.24875/RECIC.M23000414.
• [19] Gol ino L ,Caia zzo G,Cala bròP,et al. Excimer l a s e r technology in percutaneous coronary interventions:cardiovascular laser society's position paper[J]. Int J Cardiol,2022,350:19-26. DOI:10.1016/j.ijcard.2021.12.054.
• [20] Riley RF,Henry TD,Mahmud E, et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease[J]. Catheter Cardiovascular Intervention,2020,96(2):345-362. DOI:10.1002/ccd.28994.
• [21]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识[J].中华心血管病杂志，2023,51(2):109-124.DOI:10.3760/cma.j.cn112148-20220602-00436.
• [22]何攀，史杨，陈海威，等.不同对比剂浓度对准分子激光消蚀作用的影响：体外研究[J].中国介入心脏病学杂志，2024,32(1):39-44. DOI:10. 3969/j. issn. 1004-8812. 2024. 01. 008.
• [23] Sintek M,Coverstone E,Bach R,et al. Excimer l a s e r coronary angioplasty in coronary lesions:use and safety from the NCDR/CATH PCI registry[J]. Circulation Cardiovasc Interv,2021,14(7):e010061. DOI:10.1161/CIRCINTERVENTIONS.120.010061.
• [24] Moussa ID,Mohananey D,Saucedo J,et al. Trends and outcomes of restenosis after coronary stent implantation in the United State[J]. J Am Coll Cardiol,2020,76(13):1521-1531. DOI:10.1016/j.jacc.2020.08.002.
• [25]何攀，汪奇.准分子激光辅助治疗冠状动脉支架内再狭窄的研究进展[J].中国介入心脏病学杂志，2022,30(9):693-696. DOI:10. 3969/j. issn. 1004-8812. 2022. 09. 010.
• [26]杨丽霞，周玉杰，王志坚，等.联合应用准分子激光冠状动脉斑块消融术和药物涂层球囊治疗冠状动脉支架内再狭窄的观察性研究[J].中国医药，2020,15(8):1174-1177.DOI:10.3760/j.issn.1673-4777.2020.08.006.
• [27] Ishihara T,Dohi T,Nakamura D,et al. Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment[J]. Int J Cardiol,2021,339:28-32. DOI:10.1016/j.ijcard.2021.07.019.
• [28] Sato T,Tsuchida K,Yuasa S,et al. The eff ect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon:insights from optical frequency domain imaging analysis[J]. Lasers Med Sci,2020,35(2):403-412. DOI:10.1007/s10103-019-02833-1.
• [29]何攀，杨俊杰，陈海威，等.准分子激光冠状动脉成形术联合药物涂层球囊治疗支架内再狭窄的即刻管腔获益及与光学相干断层成像下不同内膜组织特征间的关系[J]，中国循环杂志，2024,39(2):133-139. DOI:10.3969/j.issn.1000-3614.2024.02.005.
• [30]王宁远，冯欢欢，王威，等.光学相干断层成像指导准分子激光联合药物涂层球囊治疗复发性支架内再狭窄的初步研究[J].中国介入心脏病学杂志，2023,31(8):579-584.DOI:10.3969/j.issn.1004-8812.2023.08.03.
• [31] Dahm JB. Excimer laser coronary angioplasty(ELCA)for diff use in-stent restenosis:benefi cial long-term results after su ffi cient debulking with a lesion-specifi c approach using various laser catheters[J]. Lasers Med Sci,2001,16(2):84-89.DOI:10.1007/pl00011347.
• [32] Ichimoto E,Kadohira T,Nakayama T,et al. Long-term clinical outcomes after treatment with excimer laser coronary atherectomy for in-stent restenosis of drug-eluting stent[J]. Int Heart J,2018,59(1):14-20. DOI:10.1536/ihj.16-638.
• [33] Dahm JB,Kuon E,Vogelgesang D,et al. Relation o f d e g r e e of laser debulking of in-stent restenosis as a predictor of restenosis rate[J]. Am J Cardiol,2002,90(1):68-70.DOI:10.1016/S0002-9149(02)02392-5.
• [34] Lee T,Shlofmitz RA,Song L,et al. The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography[J]. EuroIntervention,2019,15(3):e279-e288.DOI:10.4244/EIJ-D-18-00139.
• [35] Rhee TM,Lee JM,Shin ES,et al. Impact of optimized procedure-related factors in drug-eluting balloon angioplasty for treatment of in-stent restenosis[J]. JACC Cardiovasc Interv,2018,11(10):969-978. DOI:10.1016/j.jcin.2018.02.002.
• [36] He P,Chen H,Yang J,et al. Debulking with excimer laser coronary angioplasty versus balloon angioplasty in patients with in stent restenosis(ELDISR study):a randomized controlled trial[J]. Lasers Surg Med,2025,57(4):329-338. DOI:10.1002/lsm.70013.
• [37]何攀，陈海威，杨俊杰，等.准分子激光冠状动脉成形术联合药物涂层球囊在复发性支架内再狭窄病变中的运用探讨[J].中国介入心脏病学杂志，2023,31(11):849-854.DOI:10.3969/j.issn.1004-8812.2023.11.007.
• [38]《药物涂层球囊临床应用中国专家共识（第二版）》专家组.药物涂层球囊临床应用中国专家共识（第二版）[J].中国介入心脏病学杂志，2023,31(6):413-426. DOI:10.3969/j. issn. 1004-8812. 2023. 06. 003.
• [39] Klein LW,Nathan S,Maehara A,et al. SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis[J]. J Soc Cardiovasc Angiogr Interv,2023,2(4):100971. DOI:10.1016/j.jscai.2023.100971.
• [40] He P,Chen H,Yang J,et al. The e ffi cacy of an intracoronary cocktail administration in preventing no-reflow during excimer laser coronary angioplasty in patients with in-stent restenosis:a pilot study.(ELCA-cocktail study)[J]. Int J Cardiol,2025,419:132666. DOI:10.1016/j.ijcard.2024.132666.
• [41] Viceconte N,Biscione C,Tarsia G,et al. Laser“explosion”technique for treatment of unexpanded coronary stent[J].Int J Cardiol,2011,149(3):395-397. DOI:10.1016/j.ijcard.2011.03.021.
• [42] Latib A,Takagi K,Chizzola G,et al. Excimer laser lesion modification to expand non-dilatable stents:the ELLEMENT registry[J]. Cardiovasc Revasc Med,2014,15(1):8-12.DOI:10.1016/j.carrev.2013.10.005.
• [43]中国生物医学工程学会体外循环分会，侯晓彤. 2023年中国心血管外科手术和体外循环数据白皮书[J].中国体外循环杂志，2024,22(4):259-262. DOI:10.13498/j.cnki.chin.j.ecc.2024.04.02.
• [44] Goldman S,Zadina K,Moritz T,et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery:results from a Department of Veterans Affairs Cooperative Study[J]. J Am Coll Cardiol,2004,44(11):2149-2156. DOI:10.1016/j.jacc.2004.08.064.
• [45] Brilakis ES,Edson R,Bhatt DL,et al. Drug-eluting stents versus bare-metal stents in saphenous vein grafts:a doubleblind,randomised trial[J]. Lancet,2018,391(10134):1997-2007. DOI:10.1016/S0140-6736(18)30801-8.
• [46] Caliskan E,de Souza DR,B?ning A,et al. Saphenous vein grafts in contemporary coronary artery bypass graft surgery[J].Nat Rev Cardiol,2020,17(3):155-169. DOI:10.1038/s41569-019-0249-3.
• [47] Beerkens FJ,Claessen BE,Mahan M,et al. Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization[J]. Nat Rev Cardiol,2022,19(3):195-208. DOI:10.1038/s41569-021-00612-6.
• [48] Niccoli G,Di Vito L,Montone RA,et al. Excimer laser for a highly stenotic saphenous vein graft:evidence of debulking by optical coherence tomography[J]. EuroIntervention,2014,9(12):1484. DOI:10.4244/EIJV9I12A249.
• [49] Giugliano GR,Falcone MW,Mego D,et al. A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis:the Coronary graft Results following Atherectomy with Laser(CORAL)trial[J]. Cardiovasc Revasc Med,2012,13(2):84-89. DOI:10.1016/j.carrev.2012.01.004.
• [50] Niccoli G,Belloni F,Cosentino N,et al. Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease[J]. Am J Cardiol,2013,112(10):1586-1591. DOI:10.1016/j.amjcard.2013.07.015.
• [51] Han Y,Jing QM,Wang QC,et al. Percutaneous recanalization of total saphenous vein graft occlusion with excimer laser treatment[J]. J Geriatr Cardiol,2020,17(4):234-240.DOI:10.11909/j.issn.1671-5411.2020.04.006.
• [52] Mohandes M,Rojas S,Torres M,et al. Percutaneous coronary intervention of chronically occluded saphenous vein grafts using excimer laser atherectomy as an adjuvant therapy[J].Cardiovasc Revasc Med,2017,18(6S1):2-6. DOI:10.1016/j.carrev.2016.12.016.
• [53]翟光耀，孙铁男，李响，等.准分子激光冠状动脉成形术治疗大隐静脉桥血管退行性变的前瞻性研究[J].中华心血管病杂志，2023,51(5):490-496. DOI:10.3760/cma.j.cn112148-20220815-00631.
• [54] Ibanez B,James S,Agewall S,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J,2018,39(2):119-177. DOI:10.1093/eurheartj/ehx393.
• [55] Salinas P,Jimenez-Valero S,Moreno R,et al. Update in pharmacological management of coronary no-refl ow phenomenon[J]. Cardiovasc Hematol Agents Med Chem,2012,10(3):256-264. DOI:10.2174/187152512802651024.
• [56] Dong-bao L,Qi H,Zhi L,et al. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction[J]. Clin Cardiol,2010,33(12):E7-E12. DOI:10.1002/clc.20634.
• [57] Manzi MV,Buccheri S,Jolly SS,et al. Sex-related diff erences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention[J]. JACC Cardiovasc Interv,2022,15(20):2066-2076. DOI:10.1016/j.jcin.2022.08.013.
• [58] Ambrosini V,Cioppa A,Salemme L,et al. Excimer l a s e r in acute myocardial infarction:single centre experience on 66 patients[J]. Int J Cardiol,2008,127(1):98-102.DOI:10.1016/j.ijcard.2007.10.060.
• [59] Rawlins J,Sambu N,O'Kane P. Strategies for the management of massive intra-coronary thrombus in acute myocardial infarction[J]. Heart,2013,99(7):510. DOI:10.1136/heartjnl-2012-303370.
• [60]杨帮国，张紫微，尹晓梅，等.准分子激光冠状动脉成形术联合血栓抽吸术治疗急性心肌梗死合并右冠状动脉大量血栓3例[J].中国介入心脏病学杂志，2023,31(12):955-960.DOI:10.3969/j.jssn.1004-8812.2023.12.011.
• [61] Topaz O,Ebersole D,Das T,et al. Excimer laser angioplasty in acute myocardial infarction(the CARMEL multicenter trial)[J]. Am J Cardiol,2004,93(6):694-701.DOI:10.1016/j.amjcard.2003.11.050.
• [62] Tonomura D,Shimada Y,Yamanaka Y,et al. Laser vaporization of atherothrombotic burden before drug-coated balloon application in ST-segment elevation myocardial infarction:two-year outcomes of the laser-DCB trial[J]. Catheter Cardiovasc Interv,2022,99(6):1758-1765. DOI:10.1002/ccd.30149.
• [63] Shishikura D,Otsuji S,Takiuchi S,et al. Vaporizing thrombus with excimer laser before coronary stenting improves myocardial reperfusion in acute coronary syndrome[J]. Circ J,2013,77(6):1445-1452. DOI:10.1253/circj.CJ-12-1064.
• [64]王位，韩渊，赵巍，等.准分子激光冠脉消融术在急性ST段抬高型心肌梗死直接经皮冠脉介入治疗中的应用[J].中国实用内科杂志，2020,40(3):225-230. DOI:10.19538/j.nk2020030110.
• [65] Arai T,Tsuchiyama T,Inagaki D,et al. Benefi ts of excimer laser coronary angioplasty over thrombus aspiration therapy for patients with acute coronary syndrome and thrombolysis in myocardial infarction flow grade 0[J]. Lasers Med Sci,2022,38(1):13. DOI:10.1007/s10103-022-03691-0.
• [66] Shimojo K,Shibata N,Takagi K,et al. Excimer laser coronary angioplasty versus manual aspiration thrombectomy in patients with ST-segment elevation myocardial infarction:analyzed by nuclear scintigraphy[J]. Int J Cardiovasc Imaging,2023,39(4):831-842. DOI:10.1007/s10554-022-02771-0.
• [67] Yamanaka Y,Shimada Y,Tonomura D,et al. Laser vaporization of intracoronary thrombus and identifying plaque morphology in ST-segment elevation myocardial infarction as assessed by optical coherence tomography[J]. J Interv Cardiol,2021,2021:5590109. DOI:10.1155/2021/5590109.
• [68] Masuda R,Shibui T,Mizunuma Y,et al. Impact of small diameter and low level of emission laser coronary atherectomy in patients with acute myocardial infarction[J]. Lasers Med Sci,2022,37(3):1567-1573. DOI:10.1007/s10103-021-03405-y.
• [69]中华医学会心血管病学分会，中华心血管病杂志编辑委员会. ST段抬高型心肌梗死患者急诊PCI微循环保护策略中国专家共识[J].中华心血管病杂志，2022,50(3):221-230.DOI:10.3760/cma.j.cn112148-20211112-00987.